Safety and efficacy of a recombinant FeLV vaccine combined with a live feline rhinotracheitis, calicivirus and panleukopenia vaccine.
Gueguen
S
S
Virbac Laboratories, Carros, France.
Martin
V
V
Bonnet
L
L
Saunier
D
D
Mähl
P
P
Aubert
A
A
D000818:Animals; D017250:Caliciviridae Infections / Q000517:prevention & control / Q000662:veterinary*; D017927:Calicivirus, Feline / Q000276:immunology; D002415:Cats; D005254:Feline Panleukopenia / Q000276:immunology / Q000517:prevention & control*; D028301:Feline Panleukopenia Virus / Q000276:immunology; D005260:Female; D005256:Leukemia Virus, Feline / Q000276:immunology*; D016582:Leukemia, Feline / Q000276:immunology / Q000517:prevention & control*; D008297:Male; D018111:Pneumovirus / Q000276:immunology; D018186:Pneumovirus Infections / Q000517:prevention & control / Q000662:veterinary*; D014611:Vaccination / Q000009:adverse effects / Q000662:veterinary*